Efficacy of nitroglycerin inhalation in reducing pulmonary arterial hypertension in children with congenital heart disease

Inhaled nitroglycerin significantly decreases systolic, diastolic and mean pulmonary artery pressure as well as PVRI without affecting systemic haemodynamics, and thus can be used as a therapeutic modality for acute reduction of PAH in children with congenital heart disease.